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DNA replication on the lagging strand occurs via the synthesis
and maturation of Okazaki fragments. In archaea and eukaryotes,
the enzymatic activities required for this process are supplied by
a replicative DNA polymerase, Flap endonuclease 1 (Fen1) and
DNA ligase 1 (Lig1). These factors interact with the sliding clamp
PCNA (proliferating cell nuclear antigen) providing a potential
means of co-ordinating their sequential actions within a higher
order assembly. In hyperthermophilic archaea of the Sulfolobus
genus, PCNA is a defined heterotrimeric assembly and each
subunit interacts preferentially with specific client proteins. We
have exploited this inherent asymmetry to assemble a PCNA–
polymerase–Fen1–ligase complex on DNA and have visualized it
by electron microscopy. Our studies reveal the structural basis of
co-occupancy of a single PCNA ring by the three distinct client
proteins.
Key words: DNA replication, Okazaki fragment maturation,
proliferating cell nuclear antigen (PCNA), single particle electron
microscopy.
INTRODUCTION
DNA replication requires the co-ordination of a multitude of
proteins to create error-free daughter DNA strands. The two
daughter strands are synthesized with different mechanisms.
On the lagging strand, short RNA-primed Okazaki fragments
are synthesized. RNA primers are then removed and replaced
with DNA. The resulting DNA fragments are finally ligated to
ensure strand continuity. Sulfolobus solfataricus has a simplified
toolset for DNA replication compared with eukaryotes and is
therefore a useful model system for the study of replication
proteins [1]. In particular, S. solfataricus encodes a subset of
the eukaryotic Okazaki fragment maturation factors, among
which are the proliferating cell nuclear antigen (PCNA), as
well as DNA polymerase B1, the flap endonuclease, Fen1 (Flap
endonuclease 1) and an ATP-dependent DNA ligase, Lig1 (ligase
1). These proteins are necessary and sufficient for concerted
DNA synthesis, RNA primer removal and strand ligation in vitro
[2]. In S. solfataricus, PCNA is a heterotrimeric assembly
where each subunit interacts preferentially with specific client
proteins [1]. In the context of Okazaki fragment maturation,
S. solfataricus (Sso) PCNA1 specifically interacts with Fen1,
SsoPCNA2 with the replicative DNA polymerase B1 (PolB1) and
SsoPCNA3 with Lig1. It is unclear how PCNA effects hand-off
of DNA from polymerase and Fen1 to DNA ligase, thereby co-
ordinating Okazaki fragments maturation. Biochemical studies
have put forward a molecular tool-belt model, although this
remains controversial [3–5]. However, recent biochemical studies
[2] support a model where a single PCNA ring assembles an
Okazaki fragment maturation complex composed of PolB1, Fen1
and Lig1. To address the structural basis of co-ordination of
polymerase, flap nuclease and ligase activities, we assembled
the PCNA–PolB1–Fen1–Lig complex on DNA and visualized
it by electron microscopy (EM). Our study reveals that SsoPCNA
simultaneously co-ordinates the three client proteins and, thus,
facilitates co-ordination of functions in time and space in a
molecular tool-belt.
MATERIALS AND METHODS
Protein purification
His-SsoPCNA1/2/3, His-SsoPolB1, SsoFen1 and SsoLig1
expression constructs were generated previously [1,6]. All
proteins were over-expressed in Escherichia coli Rosetta (DE3)
pLysS (Novagen). Cells were grown to D600 = 0.4–0.6 before
induction with 1 mM IPTG for 3 h at 37 ◦C. Cells were harvested
by centrifugation at 3980 g for 15 min. Cells expressing His-
SsoPCNA1/2/3 were resuspended in 20 mM HEPES, pH 8.0,
300 mM NaCl and protease inhibitors. Extract was lysed
by sonication before centrifugation at 20100 g for 30 min.
Supernatant was heated to 75 ◦C for 25 min before further
centrifugation. The supernatant was purified by passage through
1 ml HisTrap columns (GE Healthcare) and eluted fractions
were loaded on to a Superose 10/300 gel-filtration column pre-
equilibrated in 20 mM HEPES, pH 8.0, and 300 mM NaCl.
Protein-containing fractions were pooled and stored at − 80 ◦C.
Cells expressing SsoPolB1 were resuspended in 10 mM HEPES,
pH 7.5, 100 mM NaCl, 1 mM DTT with protease inhibitors,
lysed by sonication and centrifuged at 20100 g for 30 min. The
supernatant was incubated for 20 min at 65 ◦C before further
centrifugation. The supernatant was loaded on to a HiTrap
heparin column pre-equilibrated in buffer 10 mM HEPES, pH 7.5,
Abbreviations: FAM, 6-carboxyfluorescein; Fen1, Flap endonuclease 1; FSC, Fourier Shell Correlation; hFen1, human Fen1; Lig1, ligase 1; IDCL,
interdomain connector loop; PCNA, proliferative cell nuclear antigen; PIP, PCNA-interacting peptide; PolB1, polymerase B1; Sso, Sulfolobus solfataricus;
TBE, Tris/borate/EDTA.
1 Present address: Department of Biology, McGill University, Montreal, Quebec, Canada H3G 0B1
2 Correspondence may be addressed to either of these authors (email laura.spagnolo@ed.ac.uk or email stedbell@imap.iu.edu).
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100 mM NaCl and 1 mM DTT, and eluted over a 75-ml linear
gradient of 100–1000 mM NaCl. Protein-containing fractions
were loaded on to a Superose 10/300 gel-filtration column
pre-equilibrated in 10 mM HEPES, pH 7.5, 500 mM NaCl and
1 mM DTT. Protein-containing fractions were diluted 5-fold in
10 mM HEPES and pH 7.5, 1 mM DTT, loaded on to a HiTrap
S column (GE Healthcare) pre-equilibrated in buffer 10 mM
HEPES, pH 7.5, 100 mM NaCl and 1 mM DTT, and eluted over a
30-ml linear gradient of 100–1000 mM NaCl. Protein-containing
fractions were pooled and stored at − 80 ◦C. Cells expressing His-
SsoLig1 were ground in liquid nitrogen, resuspended in 20 mM
HEPES, pH 7.5, and 300 mM NaCl with protease inhibitors and
incubated for 25 min at 75 ◦C before centrifugation at 20100 g
for 30 min. The supernatant was loaded on to a 1 ml HisTrap
column (GE Healthcare) and eluted with 500 mM imidazole.
Eluted fractions were loaded on a Superose 10/300 gel filtration
column (GE Healthcare) pre-equilibrated in 10 mM HEPES,
pH 8.0, 150 mM NaCl and 14 mM 2-mercaptoethanol. Protein-
containing fractions were diluted 2-fold in 10 mM HEPES pH 8.0
14 mM 2-mercaptoethanol, loaded on to a HiTrap Q column
(GE Healthcare) pre-equilibrated in 10 mM HEPES, pH 8.0,
75 mM NaCl and 14 mM 2-mercaptoethanol, and eluted over a
30-ml linear gradient of 75–1000 mM NaCl. Protein-containing
fractions were pooled and stored at − 80◦C SsoFen1 was purified
as described previously [7]. Extracts were lysed by sonication,
clarified by centrifugation before incubation for 15 min at 75 ◦C
and further centrifugation. The supernatant was purified by
passage through a HiTrap Heparin column (GE Healthcare)
and a Superose gel-filtration column (GE Healthcare). Protein-
containing fractions were pooled and stored at − 80 ◦C.
DNA oligonucleotides
DNA oligonucleotides were purchased from Sigma-Genosys.
The sequences were the following (mismatch shown in
bold and flap underlined): upstream: 5′-CAGGTGGGCTG-
CGGTCACGTTGACTAGGGTCG-3′; downstream: 5′-
CAAGCAGTCCTAACTTTGAGGCAGAGTCCCCCACCTAA-
CTTTAA-3′; template: 5′-TTAAAGTTAGGTGGGGGACTC-
TGCCTCAAGACGGTAGTCAACGTGACCGCAGCAAACC-
TG-3′.
Purification of PCNA–PolB1–Lig1–Fen1–DNA complex on GraFix
gradients
DNA mimicking two adjacent Okazaki fragments was prepared
at a final concentration of 30 μM in a total volume of 10 μl.
Oligonucleotides were mixed together and incubated in a
thermocycler for 80 min at a temperature decreasing from 95 ◦C to
20 ◦C. SsoPCNA1/2/3 (1.4 μM) was pre-incubated with 1.7 μM
annealed DNA in 10 mM HEPES, pH 8.0, 150 mM NaCl and
5 mM MgCl2 at 50 ◦C for 50 min in a reaction volume of 175 μl.
Following this pre-incubation, SsoPolB1, SsoLig1 and SsoFen1
were added into the reaction mix to a final concentration of
1.25 μM in a reaction volume of 200 μl and incubated for a
further 30 min at 50 ◦C. The protein–DNA complex was then
purified according to the GraFix protocol [8] using a 0–30%
glycerol gradient combined with a 0.25–0.8% glutaraldehyde
gradient, in buffer containing 10 mM HEPES, pH 8.0, 150 mM
NaCl and 5 mM MgCl2.
Western blots
Fractions collected from GraFix were separated on a 4–12%
Bis-Tris precast gradient gel (NuPage, Invitrogen), transferred
to a nitrocellulose membrane and probed with polyclonal
antibodies anti-PCNA, anti-PolB1, anti-Lig1 and anti-FEN1.
Rabbit polyclonal antibodies were described by Beattie and Bell
[2].
Electron microscopy
PCNA–PolB1–Fen1–Lig1 bound to DNA was studied by negative
staining EM and single particle analysis. Data were collected
on a FEI F20 FEG microscope, equipped with an 8k×8k CCD
(charged-couple device) camera. Images were collected under low
dose mode at a magnification of 50000×, at a final sampling of
1.6 Å/pixel (0.16 nm/pixel) at the specimen level. Single particle
images were selected interactively using the Boxer program from
the EMAN single particle analysis package [9] and extracted into
boxes. Image processing was performed using the IMAGIC-5
package [10] and EMAN [9]. The dataset was re-sampled at 3.2
Å/pixel. A total of 8206 images were band-pass filtered with a
high pass cut-off of 200 Å and a low pass cut-off of 1 Å. The
single particle images were analysed by Multivariate Statistical
Analysis with IMAGIC-5 [10]. The dataset was subjected to
successive rounds of alignment and classification in order to
improve the resulting image class-averages. Selected PCNA–
PolB1–Fen1–Lig1–DNA class-averages were used to calculate a
starting 3D volume by common lines using the Euler program in
IMAGIC-5. The PCNA–PolB1–Fen1–Lig1–DNA structure was
refined by projection matching using the Refine program in
EMAN until the map converged. The number of particles used
in the final reconstruction was 5672. The resolution of the map
was calculated as 22 Å by FSC (Fourier Shell Correlation) (0.5).
Figures were prepared with Chimera [11]. The PCNA–PolB1–
Fen1–DNA structure was solved using the EMD-5220 map [12]
as a starting model and refined with EMAN using 6878 images
sampled at 6.4 Å/pixel to a resolution of ∼30 Å.
Activity assays
Flap cleavage assays were assembled with the indicated proteins
and DNA, all components at 1.5 μM in a 20 μl reaction volume
containing 10 mM HEPES, pH 8.0, 150 mM NaCl and 5 mM
MgCl2. The DNA oligonucleotides were the same as those
used in GraFix with the exception that the downstream primer
had a 3′ FAM (6-carboxyfluorescein) fluorophore attached. As
with the GraFix procedure, DNA was pre-incubated with PCNA
for 50 min at 50 ◦C, prior to addition of Fen1 and incubation
for a further 30 min at 50 ◦C. Reactions were terminated
by addition of 20 μl of 95% formamide containing 20 mM
EDTA, pH 8.0, and 0.005% Bromophenol Blue. Samples were
boiled for 5 min then rapidly chilled on ice prior to loading
on a 12% denaturing polyacrylamide sequencing gel [19:1
acrylamide/bisacrylamide in 1 × TBE (Tris/borate/EDTA)]. DNA
was visualized by detection of the FAM fluorophore using a
Typhoon 9210 (GE Healthcare) imaging system.
DNA ligase reaction mixtures (20 μl) contained 50 mM
Tris/HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP,
100 μg/ml BSA, 50 nM DNA substrates, 125 nM ligase and
indicated amounts of PCNA (12 nM, 1.2 nM, 120 pM) and
were incubated for 30 min at 55 ◦C. Reactions were terminated
by addition of 20 μl of loading dye (8 M urea, 1 × TBE and
0.05% Bromophenol Blue). Samples were boiled for 5 min
at 100 ◦C. Reaction products were resolved by electrophoresis
through a 12% polyacrylamide, 8 M urea, 1 × TBE gel. DNA was
visualized by detection of the CY5 fluorophore using a Typhoon
9210 (GE Healthcare) imaging system.
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Figure 1 Purification of the PCNA–PolB1–Fen1–Lig1–DNA complex of S. solfataricus
(A) DNA structure used in the GraFix input. (B) SDS/PAGE analysis of fractions from a GraFix gradient. (C) Comparison between control fractions from gradients run without cross-linker and GraFix
fractions gluth, glutaraldehyde. (D) The presence of all four proteins in the cross-linked samples was assessed by Western blotting. (E) Sample screening: the complex fractionated from pycnic
gradients not containing glutaraldehyde disassembles upon EM sample preparation. (F) Sample screening: samples collected from GraFix gradients are stable during negative staining sample
preparation.
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Figure 2 3D-EM visualization of the PCNA–PolB1–Fen1–Lig1–DNA complex
(A) Characteristic negatively-stained micrograph. White circles are used to show single particles. (B) Reference-free class averages calculated with Imagic-5 show a three-layered architecture. Box
size: 410 A˚. (C) Reprojections and class averages for the refined 3D reconstruction. Box size: 410 A˚. (D) 3D model of the PCNA–PolB1–Fen1–Lig1–DNA complex. (E) FSC plot with 0.5 point
highlighted.
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Figure 3 Fitting the protein components within the PCNA–PolB1–Fen1–Lig1–DNA complex
(A) Back and front views of the ‘Okazakisome’ 3D-EM model. The volumes and shapes of 1UL1, 2HIV and 1SJ5 fitted in the Okazakisome map are consistent with a PCNA ring on which Fen1, LigI
and PolBI are simultaneously bound on one face of PCNA. (B and C) Structural comparison of EMD-5220 and PCNA–Pol–Fen1 on DNA. EMD-5220: PCNA is shown in grey, DNA in darker grey,
Pol is shown in blue. PCNA–Pol–Fen1 on DNA. PCNA is coloured grey, Pol is coloured blue, Fen1 is coloured pink. (D) EMD-5220 (PCNA and DNA in grey, Pol in blue), 1UL1 chain Y (pink) and
2HIV in extended conformation (green) fitted in the Okazakisome map.
Substrate 1 was prepared by annealing the following
oligonucleotides 5′ Cy5-GATCGTGGCTATTGTCGCCCTTAT-
TCCGAC and 5′ phosphate-AGTGACACATTTTTGTGTCAC-
TGTCGGAATAAGGGCGACAATAGCCACGATC and sub-
strate 2 used annealed 5′ Cy5-GATCGTGGCTATTGTCGCC-
CTTATTCCGACAGTGACACATTTTTGTGTCACT 3′ and 5′
phosphate-GTCGGAATAAGGGCGACAATAGCCACGATC 3′.
RESULTS AND DISCUSSION
We reconstituted the PCNA–PolB1–Fen1–Lig complex from
recombinant proteins loaded on a 60 bp dsDNA template featuring
a mismatch and a flap (Figure 1) and analysed it by EM coupled to
single particle analysis (Figures 2 and 3). The DNA was designed
based on a crystallographic paper on human Fen1 (hFen1) in
complex with DNA [13] and shown to be cleaved by Fen1
(Figure 4). The ‘Okazakisome’ was assembled from individually
purified components, including a fully functional PCNA molecule
in which the three subunits are expressed as a covalently-linked
concatamer [2,6], which were loaded on GraFix gradients [8].
Gradients devoid of cross-linker were run as controls. Fractions
were analysed by SDS/PAGE and Western blotting (Figures 1B–
1D) and those containing all four proteins were analysed by EM
(Figure 2). It should be noted that the presence of cross-linker
can alter the electrophoretic mobility of cross-linked complexes,
resulting in smeared bands. The presence of all four proteins in
these fractions was confirmed by MS (not shown). While the
four protein species migrate to the same glycerol concentration
in non-cross-linked as well as GraFix gradients (Figure 1C), the
complex purified in the absence of glutaraldehyde disassembles
upon preparation for EM analysis (Figures 1E and 1F), most
probably on dilution.
Reference-free 2D single particle analysis highlighted a bell-
shaped assembly (Figure 2B). Subsequent 3D analysis allowed
the reconstruction of a bell-shaped complex (Figure 2C). The
volume of this 3D reconstruction (Figure 2D) is compatible with
a molecular weight of 350 kDa, the predicted mass for the full
complex of proteins with DNA. The overall dimensions of the
complex are 160 × 150 × 95 Å (Figure 2D). FSC analysis using
the 0.5 criterion gives a resolution of ∼22 Å, compatible with
the level of detail exhibited by the 3D map. We have determined
that Fen1 is active under the conditions of complex preparation,
resulting in flap cleavage (Figure 4A).
To interpret our 3D-EM reconstruction, we used the structures
calculated for its isolated components and for the three sub-
complexes PCNA–Fen1, PCNA–PolI–DNA and PCNA–Lig1–
DNA. This fitting could lead to two different Okazakisome
architectures: one with PCNA layered between its client proteins
and the other one with PCNA carrying the three client proteins at
the front face. Sliding clamps have unique front and back faces.
Although a previous study showed that ubiquitin interacts with
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Figure 4 Activity assays
(A) Flap cleavage assay: reaction mixtures contained the indicated proteins at 1.5μM. Following termination of the cleavage reaction, samples were denatured and electrophoresed on a 12 %
denaturing polyacrylamide gel. The positions of migration of the substrate and cleavage product are indicated. The schematic diagram to the left of the gel indicates the substrate and product with
the FAM fluorophore represented by a green circle. (B) Ligation assays: reaction mixtures contained the indicated nicked hairpin DNA substrates. Relative migration of substrates (Sub1 and Sub2)
and ligation products (Prod) are indicated to the right of the gel image. Lanes 1 and 7 lacked protein. Lanes 2–5 and 8-11 contained 125 nM DNA Lig1. Lanes 3 and 9, 4 and 10 and 5 and 11 had
12 nM, 1.2 nM and 0.12 nM PCNA added respectively.
the back face of PCNA [14], it is generally believed that client
proteins interact with the front face of PCNA. Indeed, the principal
contact point on PCNA for client proteins, the IDCL (interdomain
connector loop), is found towards the front face of the PCNA ring.
Notably, the IDCL-interacting motif within the ligase, which is
required for functional interaction with PCNA, is found within a
short internal loop in the ligase [19]. Spatial constraints suggest
it is unlikely that Lig1 could dock with the IDCL of PCNA yet
be located behind the ring. Nevertheless, to discriminate between
the two possible map interpretations, we performed an activity
assay in which we tested the preference of the ligase for either
a front-face or a back-face interaction. We designed two hairpin
DNA substrates of the same overall sequence composition but
with nicks on opposite strands. The positioning of the nick 9
base pairs from the hairpin limits the length of DNA available for
interaction with Lig1 and PCNA. If PCNA functionally interacts
with Lig1 via PCNA’s front-face, then substrate 1 should reveal
PCNA-stimulated ligation; if interaction with the back-face of
PCNA stimulates ligase then substrate 2 would show PCNA-
enhancement of ligase activity. As seen in Figure 4(B), basal
ligase activity on both substrates is equivalent, however, only
substrate 1 shows PCNA-dependent stimulation of Lig1 activity.
Thus, our functional data support the fitting of all three client
proteins on the front face of the PCNA ring.
Additionally, we performed the GraFix procedure with DNA,
PolB1, Fen1 and PCNA in the absence of Lig1. The resultant
particles lack the density ascribed to Lig1 in the full Okazakisome
(Figures 3; Supplementary Figure S1).
The fully assembled Okazakisome (Figures 2 and 3) exhibits
features compatible with previous EM studies of related sub-
assemblies (PCNA–Lig–DNA [5] and PCNA–Pol–DNA [12]). To
glean insight into the mechanism by which PCNA co-ordinates
three client proteins to process Okazaki fragments, we fitted each
constituent of the assembly using Chimera, based on their volumes
and shapes (Figure 3).
It is not possible to determine unambiguously the trajectory of
DNA within the complex. This could be because the DNA we
designed to load one and only one copy of PCNA is completely
embedded in the structure. We used crystallographic structures for
the SsoPCNA ring (2NTI [15]), for the hPCNA–Fen1 complex
(1UL1 [16]) and for the SsoPCNA1/2 in complex with Fen1
(2IZO [17]) to define the position of the sliding clamp within the
map. 1UL1 and 2IZO facilitated docking and map interpretation
since they have distinct asymmetric shapes. In 1UL1, each Fen1
molecule (chains X, Y and Z in the PDB file) crystallized in a
distinct conformation [16]. We tested fitting assemblies ABCX,
ABCY and ABCZ from 1UL1. Based on the ligation experiment,
we placed the PCNA ring at one end of the EM model, which
exhibits a round shape. The complex is assembled on DNA,
therefore the central cavity of PCNA is filled. The Fen1 Y-chain
from 1UL1 was the one that could better be accommodated in
the EM density for Fen1 (Figure 3). This is analogous to what
was shown in the crystallographic study of the SsoPCNA1/‘2
dimer associated to Fen1 [17], where the conformation of the
endonuclease recalls the Y-chain in 1UL1. We used the EM
reconstructions for PCNA–LigI–DNA and PCNA–PolBI–DNA
(maps EMDB-5220 and EMDB-1485 [5,12]) as probes to assign
densities for PCNA-containing subcomplexes. To fit individual
client proteins, we used the PDB codes: 1UL1 [16] and 2IZO [17]
for the PCNA–Fen1 complex (Figure 3B), 1S5J [18] for PolB
(Figure 3C) and 2HIV [19] for the ligase.
Combining the analysis of the map with the biochemical
information available on the PCNA interaction with the client
proteins [1,2], we modelled PCNA2 interacting with the PCNA-
interacting peptide (PIP) box of PolB1 and PCNA3 with the PIP
box in Lig1. 1S5J fits extremely well in the density connecting
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PCNA2 and PCNA3 (Figure 3), forming two extensive contacts
with the PCNA ring, consistent with the EM analysis of the
PCNA–polymerase complex loaded on DNA [12].
We fitted the ligase at the front face of the PCNA ring in
our EM map using the crystallographic data for the full-length
Sulfolobus protein (2HIV [19]) and of hLigase233–919 in complex
with DNA (1X9 N [20]). A variety of studies have revealed that
ligase1 is a very flexible molecule [19]. We performed its fitting
placing the PIP-box containing nucleotide close to PCNA3, in
the extended conformation of 2HIV, the crystal structure for
the DNA-free ligase [19]. The model shown in Figure 3 is in
very good agreement with the 3D superposition of PCNA–Pol,
PCNA–Fen1 and PCNA–Lig1 (1UL1, EMDB-5220 and EMDB-
1485). The main difference is the extended conformation of the
ligase. The conformational malleability of Lig1 is highlighted
by crystallographic structures which have revealed that ligase
fully encircles the nicked-DNA substrate to effect ligation. We
speculate that when ligase adopts this final conformation, it may
displace DNA polymerase and Fen1, allowing their recycling to
the next Okazaki fragment.
To further confirm the fitting of the ligase within the
Okazakisome, we assembled a partial complex composed of
PCNA–Pol–Fen1 on DNA. We determined its 3D structure using
the EMD-5220 map as a starting model (Supplementary Figure
S1). We compared the PCNA–Pol starting model (Figure 3B)
with our PCNA–Pol–Fen1 assembly (Figure 3C) and clearly
saw a density (coloured pink in Figure 3C) compatible with the
speculated position of Fen1 within the PCNA ring. Fitting EMD-
5220, 1UL1 (chain Y) and 2HIV in the Okazakisome (Figure 3D)
is compatible with Lig1 in an extended conformation on the front
face of the assembly.
Conclusions
According to our structure, PCNA can load one client protein per
subunit, forming a stable complex on DNA. The positioning of
ligase in its extended conformation prevents steric clashes with
the other client proteins. Our work reveals the answer to a long-
debated biological question, showing that PCNA can orchestrate
the action of client proteins according to the ‘tool-belt model’,
instead of loading just one client protein at one given time.
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